Search results

  • Oncolytics Biotech Inc. Website
    1167 Kensington Crescent Northwest Suite 210, Calgary, AB T2N 1X7

    Oncolytics Biotech develops pelareorep, a double‑stranded RNA immunotherapy designed to treat gastrointestinal cancers such as colorectal and pancreatic tumors. The platform aims to activate patients’ immune systems to target tumor cells, offering a potential alternative to conventional chemotherap…